Comparing Arsenic-Containing Qinghuang Powder and Low-Intensity Chemotherapy in Elderly Patients with Acute Myeloid Leukemia

被引:0
|
作者
Yu-he Wu
Hai-yan Xiao
Ri-cheng Quan
Xu-dong Tang
Wei-yi Liu
Yan Lyu
Zhuo Chen
Chi Liu
Xiao-mei Hu
机构
[1] China Academy of Chinese Medical Sciences,Department of Hematology, Xiyuan Hospital
[2] China Academy of Chinese Medical Sciences,Graduate School
来源
Chinese Journal of Integrative Medicine | 2023年 / 29卷
关键词
acute myeloid leukemia; elderly; Qinghuang Powder; low-intensity chemotherapy; Chinese medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:832 / 837
页数:5
相关论文
共 50 条
  • [41] Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
    Maurillo, L.
    Spagnoli, A.
    Candoni, A.
    Papayannidis, C.
    Borlenghi, E.
    Lazzarotto, D.
    Fianchi, L.
    Sciume, M.
    Zannier, M. E.
    Buccisano, F.
    Del Principe, M. I.
    Mancini, V.
    Breccia, M.
    Fanin, R.
    Todisco, E.
    Lunghi, M.
    Palmieri, R.
    Fracchiolla, N.
    Musto, P.
    Rossi, G.
    Venditti, A.
    LEUKEMIA RESEARCH, 2023, 127
  • [42] A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Berdel, Andrew F.
    Koch, Raphael
    Gerss, Joachim
    Hentrich, Marcus
    Peceny, Rudolf
    Bartscht, Tobias
    Steffen, Bjoern
    Bischoff, Marina
    Spiekermann, Karsten
    Angenendt, Linus
    Mikesch, Jan-Henrik
    Kewitz, Tobias
    Butterfass-Bahloul, Trude
    Serve, Hubert
    Lenz, Georg
    Berdel, Wolfgang E.
    Krug, Utz
    Schliemann, Christoph
    ANNALS OF HEMATOLOGY, 2023, 102 (01) : 63 - 72
  • [43] Clinical efficacy of decitabine-containing induction chemotherapy in de novo non-elderly acute myeloid leukemia
    Zheng, Lu
    Huang, Lifang
    Hui, Yan
    Huang, Liang
    Li, Yi
    Shang, Zhen
    Wei, Jia
    Wang, Zhiqiong
    Mao, Xia
    Wang, Yin
    Xiao, Min
    Zhang, Donghua
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (06) : 1521 - 1528
  • [44] Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma
    Tong, Xiwen
    Jin, Jie
    Xu, Bin
    Su, Shuai
    Li, Li
    Li, Mengyuan
    Peng, Yizhou
    Mao, Xia
    Huang, Wei
    Zhang, Donghua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [45] Venetoclax-based low-intensity chemotherapy in the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia
    Xu, Fangfei
    Bao, Xingshuo
    Huang, Wei
    Zhou, Kuangguo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [46] Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Katie Culos
    Michael Byrne
    Clinical Hematology International, 2019, 1 (2) : 94 - 100
  • [47] The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study
    Wrzesien-Kus, A
    Robak, T
    Jamroziak, K
    Wierzbowska, A
    Dmoszynska, A
    Adamczyk-Cioch, M
    Kuliczkowski, K
    Mazur, G
    Holowiecki, J
    Konopka, L
    Maj, S
    Marianska, B
    Zawilska, K
    NEOPLASMA, 2002, 49 (06) : 405 - 411
  • [48] Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
    Daver, Naval
    Dumlao, Theresa Liu
    Ravandi, Farhad
    Pierce, Sherry
    Borthakur, Gautam
    Pemmaraju, Naveen
    Nazha, Aziz
    Faderl, Stefan
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Cortes, Jorges
    Kantarjian, Hagop
    Quintas-Cardama, Alfonso
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04) : 435 - 440
  • [49] Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia
    Jing, Yu
    Jin, Xiangshu
    Wang, Lixin
    Dou, Liping
    Wang, Quanshun
    Yao, Yushi
    Lian, Shimei
    Zhou, Jihao
    Zhu, Haiyan
    Yao, Zilong
    Gao, Lijun
    Wang, Lili
    Li, Yonghui
    Bai, Xuefeng
    Fang, Meiyun
    Yu, Li
    ONCOTARGET, 2017, 8 (32) : 53654 - 53663
  • [50] Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?
    Agarwal, Sonal
    Kowalski, Andrew
    Schiffer, Molly
    Zhao, Jennifer
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (02) : 199 - 210